Overview
Connections
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$55.5M
3 rounds on record
Latest round
$17.5M
Venture round · Feb 2025 · 20 mo ago
Backers
1
RA Capital Management
The money's age
Due for its next round
20 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 12, 2025 Board appointment Jake Simson, Director · SEC Form D Feb 28, 2025 Raised a round Venture round $17.5M · SEC Form D Dec 23, 2020 Board appointment Chenguang Zhou, Director · SEC Form D Dec 11, 2020 Raised a round Venture round $30M · SEC Form D May 5, 2017 Raised a round Venture round $8M · SEC Form D 2014 Founded
Funding rounds
RoundDateAmountInvestorsSource
Venture round Feb 2025 $17.5M — SEC Form D
Venture round Dec 2020 $30M — SEC Form D
Venture round May 2017 $8M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Vivace Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Leonard PostDirectorSEC Form D
Shuang QiaoExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
222 portfolio companies: Ventus Therapeutics, Verdiva Bio, PLEASE READ THIS AG and 219 more

People

Leonard Post
Director
Shuang Qiao
Executive Officer, Director
Jun Wu
Director
Tim Shannon
Director
Edward Hu
Director
Chenguang Zhou
Director
Jake Simson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Mateo United States
HQ

Financials

Total raised
$55.5M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $17.5M Details
Venture - Series Unknown 2020 $30M Details
Venture - Series Unknown 2017 $8M Details